Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,728 | -29,693 | -19,692 | -8,633 | -30,487 |
| Depreciation Amortization | 645 | 367 | 158 | 78 | 335 |
| Other Working Capital | 2,882 | -221 | -438 | -540 | 2,121 |
| Other Operating Activity | 9,893 | -4,871 | -1,931 | -543 | 1,688 |
| Operating Cash Flow | $-47,308 | $-34,418 | $-21,903 | $-9,638 | $-26,343 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,330 | -19,932 | -7,988 | -13,235 | N/A |
| PPE Investments | -3,262 | -2,364 | -1,213 | -373 | -508 |
| Investing Cash Flow | $-20,592 | $-22,296 | $-9,201 | $-13,608 | $-508 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 294 | 216 | 39 | 34 | N/A |
| Other Financing Activity | 39,303 | 40,446 | 41,546 | 0 | 48,627 |
| Financing Cash Flow | $39,597 | $40,662 | $41,585 | $34 | $48,627 |
| Beginning Cash Position | 35,410 | 35,410 | 35,410 | 35,410 | 13,634 |
| End Cash Position | 7,107 | 19,358 | 45,891 | 12,198 | 35,410 |
| Net Cash Flow | $-28,303 | $-16,052 | $10,481 | $-23,212 | $21,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,308 | -34,418 | -21,903 | -9,638 | -26,343 |
| Capital Expenditure | -3,262 | -2,364 | -1,213 | -373 | N/A |
| Free Cash Flow | -50,570 | -36,782 | -23,116 | -10,011 | -26,343 |